Stocks and Investing Stocks and Investing
Mon, May 3, 2021

Edward Nash Maintained (VRNA) at Strong Buy with Decreased Target to $18 on, May 3rd, 2021


Published on 2024-10-27 16:30:28 - WOPRAI, Edward Nash
  Print publication without navigation


Edward Nash of Canaccord Genuity, Maintained "Verona Pharma plc" (VRNA) at Strong Buy with Decreased Target from $19 to $18 on, May 3rd, 2021.

Edward, nor any peers, have made any analyst calls on VRNA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources